GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The hormone progesterone is readily converted to 3alpha-OH-5alpha-pregnan-20-one (3alpha,5alpha-THP) in the brains of males and females. In the brain, 3alpha,5alpha-THP acts like a sedative, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (gamma-aminobutyric acid), the brain's major inhibitory neurotransmitter. Symptoms of premenstrual syndrome (PMS), such as anxiety and seizure susceptibility, are associated with sharp declines in circulating levels of progesterone and, consequently, of levels of 3alpha,5alpha-THP in the brain. Abrupt discontinuation of use of sedatives such as benzodiazepines and ethanol can also produce PMS-like withdrawal symptoms. Here we report a progesterone-withdrawal paradigm, designed to mimic PMS and post-partum syndrome in a rat model. In this model, withdrawal of progesterone leads to increased seizure susceptibility and insensitivity to benzodiazepine sedatives through an effect on gene transcription. Specifically, this effect was due to reduced levels of 3alpha,5alpha-THP which enhance transcription of the gene encoding the alpha4 subunit of the GABA(A) receptor. We also find that increased susceptibility to seizure after progesferone withdrawal is due to a sixfold decrease in the decay time for GABA currents and consequent decreased inhibitory function. Blockade of the alpha4 gene transcript prevents these withdrawal properties. PMS symptoms may therefore be attributable, in part, to alterations in expressio…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This effect involves a 6-fold decrease in the GABAA current time constant.”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
In the citing paper
“In a progesterone-withdrawal paradigm in the rat, mimicking post-menstrual and post-partum syndromes, reduced levels of allopregnanolone enhance the expression of GABAA α4 subunit, involving GABAA reduced activity [55].”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 1×
“, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (γ-aminobutyric acid”
BackgroundPurdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90761-j · Cited by 457
Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one
Belelli, D., Bolger, M. B., & Gee, K. W. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90077-0 · Cited by 323
Wafford, K. A., Thompson, S. A., Thomas, D., Sikela, J., Wilcox, A. S., & Whiting, P. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09339-3 · Cited by 268
Devaud, L. L., Fritschy, J., Sieghart, W., & Morrow, A. L. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010126.x · Cited by 261
Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunit
Wisden, W., Herb, A., Wieland, H., Keinänen, K., Lüddens, H., & Seeburg, P. H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81076-k · Cited by 260
Twyman, R. E., & Macdonald, R. L. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019334 · Cited by 243
Bäckström, T., Zetterlund, B., Blom, S., & Romano, M. (1984) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb07807.x · Cited by 242
The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors
Brot, M. D., Akwa, Y., Purdy, R. H., Koob, G. F., & Britton, K. T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00096-4 · Cited by 234
Research works printed but not linked: 1
- Wafford, K. A. et al. Functional characterization of human GABA receptors containing the α4 subunit. Mol. Pharmacol. 50, 670–678 (1996).
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Multiple Actions of Steroid Hormones—A Focus on Rapid, Nongenomic Effects
Falkenstein, E., Tillmann, H.-C., Christ, M., Feuring, M., & Wehling, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01468-6 · Cited by 991
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Effects of gonadal steroids in women with a history of postpartum depression
Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L., & Rubinow, D. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.924 · Cited by 950
Neurosteroids: biosynthesis and function of these novel neuromodulators
Compagnone, N. A., & Mellon, S. H. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0188 · Cited by 820
Stell, B. M., Brickley, S. G., Tang, C. Y., Farrant, M., & Mody, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2435457100 · Cited by 797
Extrasynaptic GABAA Receptors: Their Function in the CNS and Implications for Disease
Brickley, S. G., & Mody, I. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.012 · Cited by 676
“…with premenstrual dysphoric disorder (PMDD) has been linked to neurosteroid regulation of tonic inhibition in animals (Maguire et al., 2005; Smith et al., 1998) and the discrepancy between extrasynaptic GABAAR number and postpartum levels of the progesterone metabolite allopregnanolone has…”
BackgroundMaguire, J. L., Stell, B. M., Rafizadeh, M., & Mody, I. (2005) · Nature Neuroscience · doi:10.1038/nn1469 · Cited by 644
Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives
Rupprecht, R., & Holsboer, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01399-5 · Cited by 633
Mehta, A. K., & Ticku, M. K. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00052-6 · Cited by 625
Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors
Brown, N., Kerby, J., Bonnert, T. P., Whiting, P. J., & Wafford, K. A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704795 · Cited by 603
“…in circulating levels of the progesterone metabolite 3a-OHpregnan-5a-ol-20-one can be observed during menstrual and pregnancy cycles and have been shown to result in upregulation of the a4 subunit and corresponding changes in the properties of hippocampal GABAA receptors (Smith et al., 1998).”
Background(2010) · Progress in Brain Research · doi:10.1016/b978-0-444-53630-3.00008-7 · Cited by 584
“Withdrawal from chronic progesterone or allopregnanolone has been shown to be associated with enhanced expression of GABA-A receptor α4 subunit (Smith et al., 1998), a molecular signal for increased neuronal excitability and seizure susceptibility.”
BackgroundNeurobiological Mechanisms of the Onset of Puberty in Primates*
Terasawa, E., & Fernandez, D. L. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0418 · Cited by 564
“1) Changes in the subunit composition of GABAA receptors occur during maturation of the brain (215, 241, 291) or under different physiological conditions (292), whereby the response to GABA varies, as discussed in a previous section.”
BackgroundNongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561
Hormones and mood: from menarche to menopause and beyond
Steiner, M. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00432-9 · Cited by 558
Neurosteroids: biochemistry and clinical significance
Mellon, S. H., & Griffin, L. D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00503-3 · Cited by 538
Neurosteroid modulation of GABAA receptors
Lambert, J. J., Belelli, D., Peden, D. R., Vardy, A. W., & Peters, J. A. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.001 · Cited by 493
Endocrine factors in the etiology of postpartum depression
Bloch, M., Daly, R. C., & Rubinow, D. R. (2003) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(03)00034-8 · Cited by 476
Extrasynaptic GABA A Receptors: Form, Pharmacology, and Function
Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., & Cope, D. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3340-09.2009 · Cited by 464
“However, notwithstanding the fact that synaptic and extrasynaptic GABAARs can be distinguished by classical GABAAR antagonists in some neurons (Park et al., 2006), the specific roles of different subtypes of GABAARs will only be determined by the development of neuron-specific and/or conditional…”
BackgroundThe role of reproductive hormones in postpartum depression
Schiller, C. E., Meltzer-Brody, S., & Rubinow, D. R. (2015) · CNS Spectrums · doi:10.1017/s1092852914000480 · Cited by 451
Estrous cycle influences the response of female rats in the elevated plus-maze test
Marcondes, F. K., Miguel, K. J., Melo, L. L., & Spadari-Bratfisch, R. C. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00593-5 · Cited by 449
The role of GABAA receptors in the acute and chronic effects of ethanol: a decade of progress
Kumar, S., Porcu, P., Werner, D. F., Matthews, D. B., Diaz-Granados, J. L., Helfand, R. S., & Morrow, A. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1562-z · Cited by 431
“However, selective modulation of α4 subunit expression in the hippocampus, using antisense oligonucleotides, has been shown to significantly alter the functional properties of GABAA receptors and modulate steroid withdrawal excitability (Moran et al. 1998;Smith et al. 1998).”
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties
Rupprecht, R. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00064-1 · Cited by 427
Concas, A., Mostallino, M. C., Porcu, P., Follesa, P., Barbaccia, M. L., Trabucchi, M., Purdy, R. H., Grisenti, P., & Biggio, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13284 · Cited by 421
Epperson, C. N., Haga, K., Mason, G. F., Sellers, E., Gueorguieva, R., Zhang, W., Weiss, E., Rothman, D. L., & Krystal, J. H. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.851 · Cited by 399
Menstrual cycle effects on cortical excitability
Smith, M. J., Keel, J. C., Greenberg, B. D., Adams, L. F., Schmidt, P. J., Rubinow, D. A., & Wassermann, E. M. (1999) · Neurology · doi:10.1212/wnl.53.9.2069 · Cited by 394
Schumacher, M., Mattern, C., Ghoumari, A., Oudinet, J. P., Liere, P., Labombarda, F., Sitruk-Ware, R., De Nicola, A. F., & Guennoun, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.004 · Cited by 355
“…with increased a4 subunit expression are encountered during the estrous cycle and at parturition, and they have been related to premenstrual and post-partum symptoms: increased anxiety, seizure susceptibility, depression and insensitivity to benzodiazepine sedatives (Smith et al., 1998a,b).”
BackgroundPark-Chung, M., Malayev, A., Purdy, R. H., Gibbs, T. T., & Farb, D. H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01381-5 · Cited by 352
Effects of ovarian hormones on human cortical excitability
Smith, M. J., Adams, L. F., Schmidt, P. J., Rubinow, D. R., & Wassermann, E. M. (2002) · Annals of Neurology · doi:10.1002/ana.10180 · Cited by 355
Smith, S. S., Gong, Q. H., Li, X., Moran, M. H., Bitran, D., Frye, C. A., & Hsu, F.-C. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05275.1998 · Cited by 349
Self-citationNeuroprotective Effects of Female Gonadal Steroids in Reproductively Senescent Female Rats
Alkayed, N. J., Murphy, S. J., Traystman, R. J., & Hurn, P. D. (2000) · Stroke · doi:10.1161/01.str.31.1.161 · Cited by 333
The influence of subunit composition on the interaction of neurosteroids with GABAA receptors
Belelli, D., Casula, A., Ling, A., & Lambert, J. J. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00172-7 · Cited by 334
Hormonally regulated α4β2δ GABAA receptors are a target for alcohol
Sundstrom-Poromaa, I., Smith, D. H., Gong, Q. H., Sabado, T. N., Li, X., Light, A., Wiedmann, M., Williams, K., & Smith, S. S. (2002) · Nature Neuroscience · doi:10.1038/nn888 · Cited by 325
Self-citationFritschy, J.-M., & Brünig, I. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00037-8 · Cited by 324
Cagetti, E., Liang, J., Spigelman, I., & Olsen, R. W. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.53 · Cited by 320
Chandra, D., Jia, F., Liang, J., Peng, Z., Suryanarayanan, A., Werner, D. F., Spigelman, I., Houser, C. R., Olsen, R. W., Harrison, N. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604304103 · Cited by 314
VanDoren, M. J., Matthews, D. B., Janis, G. C., Grobin, A. C., Devaud, L. L., & Morrow, A. L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01982.2000 · Cited by 313
“Moreover, chronic ethanol exposure and withdrawal (Devaud et al., 1995, 1997; Matthews et al., 1998) have been shown to cause changes in GABAA receptor a4 subunit mRNA and peptide expression that mirror the effects of withdrawal from progesterone and 3a,5a-THP (Smith et al., 1998a).”
BackgroundResultBiosynthesis and action of neurosteroids
Mellon, S. H., Griffin, L. D., & Compagnone, N. A. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00109-6 · Cited by 296
Rainnie, D. G., Bergeron, R., Sajdyk, T. J., Patil, M., Gehlert, D. R., & Shekhar, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5740-03.2004 · Cited by 293
Decreased Cerebrospinal Fluid Allopregnanolone Levels in Women with Posttraumatic Stress Disorder
Rasmusson, A. M., Pinna, G., Paliwal, P., Weisman, D., Gottschalk, C., Charney, D., Krystal, J., & Guidotti, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.026 · Cited by 276
Progesterone selectively increases amygdala reactivity in women
van Wingen, G. A., van Broekhoven, F., Verkes, R. J., Petersson, K. M., Bäckström, T., Buitelaar, J. K., & Fernández, G. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002030 · Cited by 273
Scharfman, H. E., Mercurio, T. C., Goodman, J. H., Wilson, M. A., & MacLusky, N. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11641.2003 · Cited by 271
Dong, E., Matsumoto, K., Uzunova, V., Sugaya, I., Takahata, H., Nomura, H., Watanabe, H., Costa, E., & Guidotti, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051628598 · Cited by 261
Distinguishing Between GABAA Receptors Responsible for Tonic and Phasic Conductances
Mody, I. (2001) · Neurochemical Research · doi:10.1023/a:1012376215967 · Cited by 261
Steroids, neuroactive steroids and neurosteroids in psychopathology
Dubrovsky, B. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.001 · Cited by 250
Carver, C. M., & Reddy, D. S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3276-5 · Cited by 248
“Induced neurosteroid withdrawal following chronic doses of progesterone or allopregnanolone in rodents has shown to increase the expression of α 4 subunit approximately 3-fold (Smith et al. 1998; Gangisetty and Reddy 2009, 2010).”
Progesterone: Therapeutic opportunities for neuroprotection and myelin repair
Schumacher, M., Guennoun, R., Stein, D. G., & De Nicola, A. F. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.001 · Cited by 246
“These withdrawal properties were attributable to increased expression of the GABA A receptor α 4 subunit (Smith et al., 1998a).”
Pinna, G., Costa, E., & Guidotti, A. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0213-2 · Cited by 245
“Withdrawal from protracted progesterone or Allo treatment has been shown to increase seizure susceptibility (Smith et al. 1998).”
BackgroundNeurosteroid regulation of GABAA receptors: Focus on the α4 and δ subunits
Smith, S. S., Shen, H., Gong, Q. H., & Zhou, X. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.008 · Cited by 244
“This effect was prevented when α4 expression was suppressed using in vivo antisense treatment, suggesting that increased α4 expression mediates the increase in convulsant activity (Smith et al., 1998a).”
BackgroundMethodSelf-citationGulinello, M., Gong, Q. H., Li, X., & Smith, S. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02565-3 · Cited by 243
Self-citationReversal of neurosteroid effects at α4β2δ GABAA receptors triggers anxiety at puberty
Shen, H., Gong, Q. H., Aoki, C., Yuan, M., Ruderman, Y., Dattilo, M., Williams, K., & Smith, S. S. (2007) · Nature Neuroscience · doi:10.1038/nn1868 · Cited by 238
Self-citationStress and neuroactive steroids
Barbaccia, M. L., Serra, M., Purdy, R. H., & Biggio, G. (2001) · International Review of Neurobiology · doi:10.1016/s0074-7742(01)46065-x · Cited by 233
The Influence of Gonadal Hormones on Neuronal Excitability, Seizures, and Epilepsy in the Female
Scharfman, H. E., & MacLusky, N. J. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00672.x · Cited by 232
Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat
Rudick, C. N., & Woolley, C. S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06532.2001 · Cited by 228
“First, prolonged IPSC decay could be caused by estrogen-induced changes in the subunit composition of postsynaptic GABAA receptors (Smith et al., 1998).”
BackgroundPreferential Coassembly of α4 and δ Subunits of the γ-Aminobutyric AcidAReceptor in Rat Thalamus
Sur, C., Farrar, S. J., Kerby, J., Whiting, P. J., Atack, J. R., & McKernan, R. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.110 · Cited by 228
The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence
Morrow, A. L., VanDoren, M. J., Penland, S. N., & Matthews, D. B. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00127-8 · Cited by 222
Regulation of GABAA Receptor Subunit Expression by Pharmacological Agents
Uusi-Oukari, M., & Korpi, E. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002063 · Cited by 213
Mohabatkar, H., Mohammad Beigi, M., & Esmaeili, A. (2011) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2011.04.017 · Cited by 214
King, S. R., Manna, P. R., Ishii, T., Syapin, P. J., Ginsberg, S. D., Wilson, K., Walsh, L. P., Parker, K. L., Stocco, D. M., Smith, R. G., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10613.2002 · Cited by 211
Neurosteroid regulation of central nervous system development
Mellon, S. H. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.011 · Cited by 209
Allopregnanolone and mood disorders
Bäckström, T., Bixo, M., Johansson, M., Nyberg, S., Ossewaarde, L., Ragagnin, G., Savic, I., Strömberg, J., Timby, E., van Broekhoven, F., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.07.005 · Cited by 206
“withdrawal model for PMDD and at that situation animals are insensitive to benzodiazepines (Gallo and Smith, 1993; Smith et al., 1998).”
Catamenial epilepsy: Definition, prevalence pathophysiology and treatment
Herzog, A. G. (2008) · Seizure · doi:10.1016/j.seizure.2007.11.014 · Cited by 208
Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors
Herd, M. B., Belelli, D., & Lambert, J. J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.007 · Cited by 206
Elevated brain monoamine oxidase A binding in the early postpartum period
Sacher, J., Wilson, A. A., Houle, S., Rusjan, P., Hassan, S., Bloomfield, P. M., Stewart, D. E., & Meyer, J. H. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.32 · Cited by 202
Herbel, G., & Boyle, P. J. (2000) · Cited by 199
Hantsoo, L., & Epperson, C. N. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100213 · Cited by 199
“Together, rodent models suggest impaired GABAA-R plasticity in response to NAS fluctuations in reproductive affective disorders such as postpartum depression and PMDD (Gallo and Smith, 1993; Gulinello et al., 2001; Reddy et al., 2012; Smith et al., 1998a; Sundstrom-Poromaa et al., 2002).”
BackgroundInfluentialNeurosteroids and GABA-A Receptor Function
Wang, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00044 · Cited by 195
“In addition, the anxiety induction was blocked if the animals were treated with α4-antisense (Smith et al., 1998; Gulinello et al., 2001).”
BackgroundInfluentialSundström-Poromaa, I., Comasco, E., Sumner, R., & Luders, E. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100856 · Cited by 191
“In addition, after long-term treatment of progesterone or after a pseudopregnancy in female rats, it was shown that symptoms of anxiety and depression are precipitated once hormones are withdrawn (Smith et al., 2007, 1998a, 1998b; Gulinello et al., 2002).”
BackgroundDevelopment of the GABAergic System from Birth to Adolescence
Kilb, W. (2012) · The Neuroscientist · doi:10.1177/1073858411422114 · Cited by 190
Adkins, C. E., Pillai, G. V., Kerby, J., Bonnert, T. P., Haldon, C., McKernan, R. M., Gonzalez, J. E., Oades, K., Whiting, P. J., & Simpson, P. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104318200 · Cited by 190
Andréen, L., Nyberg, S., Turkmen, S., van Wingen, G., Fernández, G., & Bäckström, T. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.02.003 · Cited by 189
Allopregnanolone concentrations and premenstrual syndrome
Monteleone, P., Luisi, S., Tonetti, A., Bernardi, F., Genazzani, A., Luisi, M., Petraglia, F., & Genazzani, A. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420269 · Cited by 186
Endocrine withdrawal syndromes
Hochberg, Z., Pacak, K., & Chrousos, G. P. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0014 · Cited by 181
Roca, C. A., Schmidt, P. J., Altemus, M., Deuster, P., Danaceau, M. A., Putnam, K., & Rubinow, D. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021570 · Cited by 180
A New Look at the 5?-Reductase Inhibitor Finasteride
Finn, D. A., Beadles-Bohling, A. S., Beckley, E. H., Ford, M. M., Gililland, K. R., Gorin-Meyer, R. E., & Wiren, K. M. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00053.x · Cited by 179
Update on Research and Treatment of Premenstrual Dysphoric Disorder
Cunningham, J., Yonkers, K. A., O'Brien, S., & Eriksson, E. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902891836 · Cited by 180
Reddy, D. S., & Jian, K. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169854 · Cited by 178
Skinner, D. C., Evans, N. P., Delaleu, B., Goodman, R. L., Bouchard, P., & Caraty, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10978 · Cited by 180
Reproductive Steroid Regulation of Mood and Behavior
Schiller, C. E., Johnson, S. L., Abate, A. C., Schmidt, P. J., & Rubinow, D. R. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c150014 · Cited by 176
Sex Hormones and Mood in the Perimenopause
Schmidt, P. J., & Rubinow, D. R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04982.x · Cited by 172
Guidotti, A., Dong, E., Matsumoto, K., Pinna, G., Rasmusson, A. M., & Costa, E. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00129-1 · Cited by 170
The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy
Reddy, D. S. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.02.017 · Cited by 167
“These include pseudopregnancy, chronic progesterone, and progesterone (neurosteroid) withdrawal models (Smith et al., 1998a; Moran and Smith, 1998; Reddy et al, 2001).”
BackgroundInfluentialLambert, J. J., Belelli, D., Harney, S. C., Peters, J. A., & Frenguelli, B. G. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00124-2 · Cited by 164
Shen, H., Gong, Q. H., Yuan, M., & Smith, S. S. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.026 · Cited by 163
“Acute isolation of hippocampal neurons and recording procedures Pyramidal neurons were acutely dissociated from CA1 hippocampus and THIP-gated Cl− currents analyzed using whole cell patch clamp procedures as previously described (Smith et al., 1998).”
MethodInfluentialSelf-citationMatsumoto, K., Pinna, G., Puia, G., Guidotti, A., & Costa, E. (2005) · Stress · doi:10.1080/10253890500159022 · Cited by 163
“This is an interesting observation especially when situations are considered such as progesterone withdrawal in rats (Smith et al. 1998, Follesa et al. 2001), or protracted social isolation stress in mice (Pinna et al. 2004) which are associated with an increase in the expression of these receptors.”
BackgroundBelelli, D., Herd, M. B., Mitchell, E. A., Peden, D. R., Vardy, A. W., Gentet, L., & Lambert, J. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.021 · Cited by 162
Interactions between hormones and epilepsy
Taubøll, E., Sveberg, L., & Svalheim, S. (2015) · Seizure · doi:10.1016/j.seizure.2015.02.012 · Cited by 162
“striking finding following progesterone withdrawal, a model for catamenial epilepsy, is the marked up-regulation of the alfa-4 subunit of the GABA receptor [9,54–57].”
Liang, J., Zhang, N., Cagetti, E., Houser, C. R., Olsen, R. W., & Spigelman, I. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4702-05.2006 · Cited by 161
“Analogous increases in 4 2 subunit combinations were proposed to underlie the behavioral and physiological changes induced by withdrawal from progesterone treatment, a model of premenstrual syndrome (Smith et al., 1998; Sundstrom-Poromaa et al., 2002).”
BackgroundSuda, S., Segi-Nishida, E., Newton, S. S., & Duman, R. S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.029 · Cited by 158
Sibille, E., Pavlides, C., Benke, D., & Toth, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02758.2000 · Cited by 183
“Currently, it is believed that certain forms of anxiety, such as that associated with drug withdrawal, can be linked to changes in the subunit composition of the BZ receptor (Mahmoudi et al., 1997; Smith et al., 1998).”
BackgroundEthanol regulation of γ-aminobutyric acidA receptors: genomic and nongenomic mechanisms
Kumar, S., Fleming, R. L., & Morrow, A. L. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.12.001 · Cited by 158
Neurosteroid Withdrawal Model of Perimenstrual Catamenial Epilepsy
Reddy, D. S., Kim, H., & Rogawski, M. A. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.10100.x · Cited by 157
“(41,44,45) have proposed that progesterone withdrawal is accompanied by alterations in the expression of GABAA-receptor subunits and a consequent change in GABAA-receptor properties that causes reduced inhibition and an overall increase in brain excitability.”
BackgroundAnxiolytic activity of progesterone in progesterone receptor knockout mice
Reddy, D. S., O’Malley, B. W., & Rogawski, M. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.002 · Cited by 160
Physiological modulation of GABAA receptor plasticity by progesterone metabolites
Concas, A., Follesa, P., Barbaccia, M. L., Purdy, R. H., & Biggio, G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00232-0 · Cited by 165
Reddy, D. S., & Rogawski, M. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39026-3 · Cited by 156
“Thus, after neurosteroid withdrawal, GABAA receptor currents have diminished benzodiazepine sensitivity (Costa et al., 1995; Follesa et al., 2000) and benzodiazepines exhibit reduced sedative and anticonvulsant actions (Smith et al., 1998a,b; Reddy and Rogawski, 2000).”
Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology
Rupprecht, R., di Michele, F., Hermann, B., Ströhle, A., Lancel, M., Romeo, E., & Holsboer, F. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00123-0 · Cited by 166
Bäckström, T., Haage, D., Löfgren, M., Johansson, I. M., Strömberg, J., Nyberg, S., Andréen, L., Ossewaarde, L., van Wingen, G. A., Turkmen, S., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.061 · Cited by 169
“It has also been reported that the receptor subunit composition and sensitivity to GABA modulators can be modulated by environmental factors such as stress (Biggio et al., 1990; Concas et al., 1996) and hormonal therapy (Smith et al., 1998b).”
Towers, E. B., Williams, I. L., Qillawala, E. I., Rissman, E. F., & Lynch, W. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000361 · Cited by 168
Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems
Birzniece, V., Bäckström, T. C., Johansson, I., Lindblad, C., Lundgren, P., Löfgren, M., Olsson, T., Ragagnin, G., Taube, M., Türkmen, Ş., et al. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.001 · Cited by 166
Neurosteroids in the context of stress: implications for depressive disorders
Girdler, S. S., & Klatzkin, R. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.05.006 · Cited by 148
“…neurosteroid withdrawal results in a state of anxiety and to a relative insensitivity to the anxiolytic effects of benzodiazepines and that these effects appear to be mediated by an increase in the expression of the α4-containing GABAA receptor subunit in brain (Smith et al., 1998a, 1998b, 2006).”
Background
Metadata
- Authors
- Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X.
- Corresponding author
- Smith, Sheryl S.
- ORCID
- Smith, Sheryl S.
- Venue
- Nature
- Published
- 1998-04
- Volume
- 392
- Issue
- 6679
- Pages
- 926-929
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1647312149
- Semantic Scholar
- 3539e8269bee3fd116e338cc540f9de8e78942b1
- Cited by
- 564
- References
- 31
- Citations by year
- 2026: 1 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 7 · 2016: 16 · 2015: 14 · 2014: 16 · 2013: 21 · 2012: 20
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- progesterone withdrawal, 3alpha,5alpha-THP, premenstrual syndrome, seizure susceptibility, GABA currents, gene transcription, steroid hormones, anxiety, GABAergic inhibition
- MeSH terms
- Animals, Azides, Benzodiazepines, Carbolines, Female, gamma-Aminobutyric Acid, Hippocampus, Indomethacin, Lorazepam, Pregnanolone, Premenstrual Syndrome, Progesterone, Receptors, GABA-A, RNA, Messenger, Anti-Anxiety Agents, Transcription, Genetic, Oligonucleotides, Antisense, Pyramidal Cells, Patch-Clamp Techniques, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.